Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy

Published:2014-05-19 Issue:4 Volume:20 Page:e243-e250
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Abbonizio F.¹,Giampaolo A.¹,Coppola A.²,Arcieri R.³,Hassan H. J.¹,

Affiliation:

1. Department of Haematology; Oncology and Molecular Medicine; Istituto Superiore di Sanità; Rome Italy

2. Regional Reference Centre for Coagulation Disorders; Department of Clinical and Experimental Medicine; Federico II University; Naples Italy

3. Federation of Haemophiliac Associations; Milan Italy

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12456/fullpdf

Reference42 articles.

1. Guidelines for the management of hemophilia;Srivastava;Haemophilia,2013

2. Factor VIII inhibitors in hemophilia A: rationale and latest evidence;Witmer;Ther Adv Hematol,2013

3. The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort;Astermark;Blood,2013

4. F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis;Gouw;Blood,2012

5. Environmental risk factors for inhibitor development in children with haemophilia A: a case-control study;Santagostino;Br J Haematol,2005

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic Evaluation of Immune Tolerance Induction in Children With Severe Hemophilia A and High-Responding Inhibitors: A Cost-Effectiveness Analysis of Prophylaxis With Emicizumab;Value in Health Regional Issues;2023-03

2. A Comparison of the Incidence Rate for Joint Bleeding and FVIII Consumption between On-Demand versus Prophylaxis Factor VIII Replacement Therapy and the Direct Cost of Prophylaxis Treatment in Severe Haemophilia A Patients;Malaysian Journal of Medical Sciences;2023-02-28

3. Variability of treatment modalities and intensity in patients with severe haemophilia A on prophylaxis: Results from the Italian national registry;European Journal of Haematology;2021-06-22

4. Cost of hemophilia A in Turkey: an economic disease burden analysis;Journal of Medical Economics;2021-01-01

5. National registry of haemophilia and other coagulopathies: A multisector initiative in the Colombian Health System;Haemophilia;2020-09-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3